Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8651824 | The American Journal of the Medical Sciences | 2018 | 19 Pages |
Abstract
Older patients with suspected PH often have significant cardiovascular and respiratory comorbidity. Comprehensive evaluations are needed to determine the severity of PH and associated diseases and to initiate treatment focused on FC. Patients in WHO Group 2 and mixed Group 2 and 3 were frequently identified and constituted a diagnostic and treatment challenge in this study. Older patients with PAH may benefit from PAH specific drugs.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hawa MD, Kavitha MD, Tatiana MD, Terrance MD, Victor MD, Kenneth MD,